In a recent study published in Cell, a research team led by Li Wei and Zhou Qi from the Institute of Zoology of the Chinese Academy of Sciences has developed an innovative gene-writing technology ...
A rare-disease gene therapy developed in Philadelphia has cleared a major regulatory hurdle, positioning it on an accelerated path toward approval in the United States and the ...
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies ...
Metagenomi announces successful integration of large genes in human cells using a novel, compact CAST system for potential therapeutic applications. Metagenomi, Inc., a precision genetic medicines ...
Achieved 98% manufacturing batch success rate at BaseCamp across cell therapy, viral vector, and mRNA– Positioned U.S.-based biomanufacturing ...
We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...
Intellia is adopting a distinct strategy by focusing on in-vivo gene editing, potentially redefining industry standards and expectations. Interim results from Intellia's in-vivo gene-editing program ...
The UWA Tech & Policy Lab receives funding from nationally competitive research grants and philanthropic partners. The present research was supported by GA308883: Effective Ethical Frameworks for the ...
SAN FRANCISCO--(BUSINESS WIRE)--Kamau Therapeutics ("Kamau" or "the Company"), a clinical-stage gene correction company, announced today its emergence from stealth, following a strategic transaction ...
Gene therapy is a revolutionary field in modern medicine, offering transformative potential to treat and potentially cure a wide range of genetic and acquired diseases. By addressing the root cause of ...
The Canadian government is currently considering approving the entry of gene-edited pigs into the food system. Subscribe to our newsletter for the latest sci-tech news updates. Using CRISPR ...